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Abstract 
Coeliac disease (CD) development involves genetic (HLA-
DQ2/DQ8) and environmental factors. Herein, the influence 
of the HLA-DQ genotype on the gut colonization process of 
breast-fed children was determined. Twenty newborns, with 
at least one first-degree relative with CD, were classified 
according to their HLA-DQ genotype into high, intermediate 
and low genetic risk groups, showing 24-28%, 7-8% and 
less than 1% probability to develop CD, respectively. 
Faecal microbiota was analysed at 7 days, 1 and 4 months 
of children’s age by fluorescence in situ hybridization. 
When considering all data, Bacteroides-Prevotella group 
proportions were higher (P<0.05) in the high than in the 
intermediate and low genetic risk groups. Gram-negative 
bacteria, E. coli, Streptococcus-Lactococcus, E. rectale-C. 
coccoides, sulphate-reducing bacteria, C. lituseburense 
and C. histolyticum group proportions were also significantly 
higher (P<0.05) in the high than in the low genetic risk 
group. Correlations between these bacterial groups and 
the genetic risk were also detected (P<0.05). In addition, 
the number and type of CD relative seemed to influence 
(P<0.050) these bacterial proportions in children at CD risk. 
At 4 months of age, similar relationships were established 
between the high genetic risk to develop CD and the 
proportions of Streptococcus-Lactococcus (P<0.05), E. 
rectale-C. coccoides (P<0.05), C. lituseburense (P<0.05), 
C. histolyticum (P<0.05), Bacteroides-Prevotella (P<0.10) 
groups and total Gram-negative bacteria (P<0.05). The 
results suggest a relationship between HLA-DQ genes and 
the gut microbial colonization process that could lead to a 
change in the way this disorder is investigated.    
Introduction
Coeliac disease (CD) is the commonest immune-mediated 
enteropathy triggered by the ingestion of cereal gluten 
proteins in genetically susceptible individuals. CD is a 
chronic inflammatory disorder of the small intestinal mucosa 
caused by an abnormal Th1 immune response to ingested 
gluten (Rodrigo, 2006). The typical manifestation of CD is 
the malabsorption syndrome with chronic diarrhoea, weight 
loss, abdominal distension and impaired growth (Fasano 
and Catassi, 2005). CD can develop at any age, but it often 
manifests in early childhood between 6 and 24 months of 
age after the introduction of gluten in the diet (Fasano and 
Catassi, 2005). 
 CD is strongly associated with the human leukocyte 
antigen (HLA) genes of the major histocompatibility 
complex (MHC) genomic region. Approximately 95 % of 
the patients are HLA-DQ2 or HLA-DQ8 positives; however, 
only a small percentage (20-50%) of those bearing high risk 
HLA haplotypes develop CD (Mearin et al., 2005).  Studies 
with twins showed that in 25% of the cases one twin of the 
pair did not develop CD, supporting a role for environmental 
factors in the presentation of this disorder (Greco et al., 
2002). In particular, the infant feeding pattern is thought to 
be involved in CD risk (Branski et al., 2006). Breast-feeding 
seems to exert a protective effect against CD development 
(Branski et al., 2006; Ivarsson et al., 2002), which may 
be related to its influence on the microbial colonization 
process of the newborn intestine (Sanz et al., 2008). The 
incidence of infections in early life, which may trigger a Th1 
pro-inflammatory response and disrupt the gut microbial 
balance, has also been related to an increased risk of CD 
development (Ivarsson et al., 2003; Stene et al., 2006; Sanz 
et al., 2008). 
 The microbiota rapidly colonizes the gut after birth 
and this process is influenced by a number of factors, 
including the heredity of the mother, the immediate living 
environment, the feeding practices, microbial infections, 
and the host’s genetics (Bjorkstén, 2006). The early stage 
of colonization is characterized by the presence of higher 
levels of facultative anaerobes (Enterobacteriaceae, 
Lactobacillus and Streptococcus) than anaerobic bacteria 
(e.g. Bifidobacterium, Bacteroides, Clostridium and 
Eubacterium), but these proportions are reversed within one *Corresponding author: Email: yolsanz@iata.csic.es
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week after birth. The Bifidobacterium genus is predominant 
in breast-fed infants, reaching up to 90% of the total faecal 
microbiota, whereas in formula-fed infants the microbiota 
is more heterogeneous (Salminen and Isolauri, 2006). The 
intestinal microbiota plays a pivotal role in the morphology 
and physiology of the gut, providing the basis for a healthy 
gut (Salminen and Isolauri, 2006). 
 The gut microbiota serves several functions including 
regulation of gut permeability and immunity to develop 
adequate responses to microbial and dietary antigens and 
avoid overreactions (Conte et al., 2006; Sanz et al., 2007). It 
was recently demonstrated that the neonatal gut microbiota 
plays an important role in the development of atopy. In 
particular, a lower ratio of bifidobacteria to clostridia in the 
gut microbiota at neonatal age was shown to precede the 
development of atopy (Kalliomäki et al., 2001a). A recent 
study also demonstrated that probiotic supplementation to 
mothers before delivery and to their infants could prevent 
atopic disease in children (Kalliomäki et al., 2001b). 
Differences in the composition of the gut microbiota have 
been detected between healthy controls and CD patients 
recently (Nadal et al., 2007; Sánchez et al., 2008; Collado 
et al., 2009). Nevertheless, the knowledge of the role 
played by the gut microbiota in CD is limited and there is 
no information of its possible contribution to the disease risk 
based on prospective studies. 
 The objective of this preliminary study was to determine 
whether the gut colonization pattern of newborns and 
breast-fed children could be influenced by the genetic risk 
to develop CD based on their HLA-DQ status, in order to get 
new insights into the influence of host-microbe interactions 
in this disorder. 
Materials and Methods
Subjects and samplings
This study included 20 healthy infants with at least one first-
degree relative suffering from CD. Faecal samples were 
collected from every subject at 7 days, 1 month and 4 months 
of age and kept immediately at -20ºC until analysed. DNA 
for HLA-DQ genotyping was also obtained from oral mucosa 
cells by scraping the inner side of the children’s cheek with 
sterile swabs (Copan innovation, Sarstedt, Germany) at 4 
months of age. Data on clinical and dietary history of every 
subject were recorded including type of delivery, time of 
gestation, weight, size and type of feeding (Table 1). Only 
subjects under exclusive breast-milk feeding practices 
were included in the study. The study was conducted in 
accordance with the ethical rules of the Helsinki Declaration 
(Hong Kong revision, September 1989), following the EEC 
Good Clinical Practice guidelines (document 111/3976/88 of 
July 1990) and current Spanish law which regulates clinical 
research in humans (Royal Decree 561/1993 regarding 
clinical trials). The study was approved by the local Ethic 
Committees and written informed consent was obtained 
from the parents of children included in the study.
Analysis of the faecal microbiota by fluorescence in situ 
hybridization (FISH) and flow cytometry (FCM)
Faecal samples were diluted 1 to 10 in phosphate-
buffered saline solution (PBS 130 mM sodium chloride, 
10 mM sodium phosphate, pH between 7.2 and 7.4) and 
homogenized in a Lab Blender 400 stomacher (Seward 
Medical London, UK) for 5 min. Cells were fixed overnight 
with 4% paraformaldehyde. Then, bacteria were washed 
twice with PBS and bacterial pellets were suspended in 
1:1 chilled ethanol-PBS and stored at -80ºC until analyzed 
(Nadal et al., 2007).
 The universal and group-specific probes used for 
detection of the main bacterial groups colonizing the human 
gut are shown in Table 2 (MOLBIOL, Berlin, Germany). 
The group-specific probes were labelled at the 5’-end 
with fluorescein isothiocyanate (FITC); showing green 
fluorescence. EUB 338 probe, targeting conserved sequences 
within the bacterial domain, was labelled at the 5’end with 
the indocyanine dye Cy3 showing red fluorescence, and was 
used as positive control of total bacteria (Amann et al., 1990). 
NON EUB 338 probe was labelled with FITC and used as 
negative control to eliminate the background fluorescence 
(Wallner et al., 1993). Aliquots of 45 µl fixed bacterial 
samples were incubated with 5 µl of each fluorescent probe 
(50ng/µl) in hybridisation solution (10 mM Tris–HCl, 0.9 M 
NaCl, pH 8.0, and 0.1% [w/v] sodium dodecyl sulphate) at 
appropriate temperature (45-50ºC) overnight. Hybridization 
conditions were those described by other authors (Table 
2), except for E. coli and Staphylococcus, which were 
detected by hybridisation at 50ºC, and for Lactobacillus, 
which was detected by hybridisation at 45ºC. Afterwards, 
bacterial cells were incubated with 500 µl washing solution 
(10 mM Tris–HCl, 0.9 M NaCl, pH 8.0) at the corresponding 
hybridization temperature for 30 min to remove non specific 
binding of the probes. Hybridised cells were finally pelleted 
by centrifugation (12 000 g for 5 min) and suspended in 
500 µl of PBS for flow cytometry detection. Bacterial groups 
were enumerated by combining each FITC-labelled group-
specific probe with the EUB 338-Cy3 probe, and expressed 
as a ratio of cells hybridising with the FITC-labelled specific 
probe to cells hybridising with the EUB 338-Cy3 probe This 
proportion was corrected by subtracting the background 
fluorescence obtained with the negative control probe NON 
EUB 338 (Sokol et al., 2006; Nadal et al., 2007). 
 Flow cytometry detections were performed using 
an EPICS® XL-MCL flow cytometer (Beckman Coulter, 
Florida, USA) as previously described (Nadal et al., 2007). 
This instrument is equipped with two light scatter detectors 
that measure forward (FSC) and side scatter (SSC) and 
fluorescence detectors that detect appropriately filtered 
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Table 1. Characteristics of the studied cohort of newborns  
 
 Total subjects (n=20) 
Delivery 
                               vaginal 
  
caesarean 
 
17/20 
 
3/20 
 
Size (cm) 
 
49.28 ± 2.02 
 
Weight (g) 
 
3321.94 ± 491.26 
Weeks of gestation 
 
39.16 ± 1.52 
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Table 2. Oligonucleotide probes and hybridization conditions used in FISH analysis of faecal bacteria 
 
Probe Target bacterial group Sequence (5’-3’) 
Hybridization 
conditions 
References 
Eub 338 All bacteria GCTGCCTCCCGTAGGAGT 50°C Wallner et al. (1993) 
Non EUB 338 Negative control ACTCCTACGGGAGGCAGC 50°C Wallner et al. (1993) 
Bif 164 Bifidobacterium  CATCCGGCATTACCACCC 50ºC Langendijk et al. (1995) 
Bac 303 Bacteroides/Prevotella CCAATGTGGGGGACCTT 46ºC Manz et al. (1996) 
Erec 0482 Eubacterium rectale/ Clostridium coccoides GCTTCTTAGTCARGTACCG 50ºC Franks et al. (1998) 
E.coli 1513 Escherichia coli CACCGTAGTGCCTCGTCATCA 50ºC Poulsen et al. (1994) 
Strc 493 Streptococcus/Lactococcus GTTAGCCGTCCCTTTCTGG 50°C Franks et al. (1998) 
Lab 158 Lactobacillus/other lactic acid bacteria GGTATTAGCA(T/C)CTGTTTCCA 45°C Harmsen et al. (1999) 
Sta  Staphylococcus TCCTCCATATCTCTGCGC 50°C Kempf et al.(2000) 
C. His 150 Clostridium histolyticum TTATGCGGTATTAATCT(C/T)CCTTT 50°C Franks et al. (1998) 
C. Lit 135 Clostridium lituseburense GTTATCCGTGTGTACAGGG 50°C Franks et al. (1998) 
SRB Sulphate reducing bacteria TACGGATTTCACTCCT 50°C Bullock et al. (2004) 
 
 
 
 
 
 
 
 
 
 
light at green (FL1, 525 nm) and red-orange (FL3, 620 nm) 
wavelengths. The event rate was kept at the lowest setting 
(200-300 events per second) to avoid cell overlap. A total of 
15 000 events were recorded in a list mode file and analyzed 
with the System II V.3 software (Beckman Coulter). 
HLA-DQ Genotyping
DNA was extracted from oral mucosa cells by scraping the 
inner side of the children’s cheek with sterile swabs (Copan 
innovation, Sarstedt, Germany). The cotton was cut and 
incubated in DLB buffer (100mM Tris HCL pH 7.4, 10mM 
EDTA pH 8, 10 mM NaCl per litre of distilled water); 10% 
SDS  and 10 μl proteinase K (20 mg/ml) at 65ºC for 1 h 
and then, a standard phenol-chloroform DNA extraction 
method was carried out. Extracted DNA was stored in TE 
buffer (10ml Tris HCl pH 8, 200 μl EDTA 0.5M pH 8 per 
litre of distilled water) at -20ºC until use for genotyping. The 
DNA concentration, around 50-100 μg/ml, was quantified by 
using the NanoDrop© Spectrophotometer. Low-resolution 
HLA-DQB1 typing was performed by PCR-SSP (Polymerase 
Chain Reaction-Sequence Specific Primers) analysis. Each 
PCR reaction was performed on about 60–90 ng of extracted 
DNA, 0·5 U of BIOTOOLS DNA polymerase (BIOTOOLS 
B&M S.A, Spain), 1 × PCR Master Mix (Dynal AllSet+TM 
SSP or Olerup SSPTM) containing nucleotides (200 µmol L−1 
each), PCR buffer (50 mmol L−1 KCl, 1·5 mmol L−1 MgCl2, 
10 mmol L−1 Tris–HCl pH 8·3, 0·001% w/v gelatine), 5% 
glycerol and 100 µg mL−1 cresol red, 0·25 µmol L−1 of each 
allele- or group-specific primer pair and 0·1 µmol L−1 of 
internal positive control primer pair matching a segment of 
the human growth hormone gene in a final volume of 10 µL. 
The PCR program was as follows: an initial denaturation 
step at 94 °C for 2 min, followed by 10 two-temperature 
cycles (94 °C for 10 s and 65 °C for 60 s) and finally by 
20 three-temperature cycles (94 °C for 10 s, 61 °C for 50 s 
and 72 °C for 30 s). Detection of amplified alleles was 
carried out on a 2% agarose gel after electrophoresis and 
ethidium bromide staining. Although the allele DQB1*02 is 
determinant to be DQ2, HLA-DQA1 alleles were genotyped 
in a stepwise fashion for a high resolution typing to sharpen 
the risk classification of each individual. 
Statistical analysis
Statistical analysis was done using the SPSS 15.0 software 
(SPSS Inc, Chicago, IL, USA). To determine whether the 
microbiological data could be adequately modelled by a 
normal distribution, Kolmogorov-Smirnov test was run and 
the distribution of the data resulted non normal at 90-99% of 
confidence. Therefore, microbiological data are expressed 
as medians of bacterial proportions with interquartile ranges 
(IQR) and the differences were determined by applying the 
Mann–Whitney U and Wilcoxon W tests for non-parametric 
data. The presence of correlations between factors was 
tested by Spearman non parametric correlation coefficient. 
A mixed model analysis was applied to study the effect of the 
genetic risk on bacterial counts, and the interactions among 
all factors with the time sampling as a repeated measure. 
Significant differences were established at P value less than 
0.10 and 0.05.
Results
Subjects and HLA genotypes
The cohort of 20 newborns included in this study were born 
at term and they had uncomplicated perinatal period. They 
showed a mean gestational age of 39.16 ± 1.52 weeks, and 
a mean weight and size of 3321.94 ± 491.26 g and 49.28 ± 
2.02 cm, respectively (Table 1). Most newborns were naturally 
delivered (17 out of 20) and all were under exclusive breast-
milk feeding. This cohort of children was analysed for the 
HLA class II DQA1 and DQB1 genotypes. The children were 
classified in three main CD risk groups, according to their 
DQ haplotype, loosely based on the criterion of Bourgey 
et al. (2007) and considering the HLA distribution of the 
Eastern Spanish population (Capilla et al., 2007). The first 
one included those individuals carrying the DQ2 haplotype in 
both cis (DQA1*0501-DQB1*0201 in homozygosis) or trans 
conformation (DQA1*0201-DQB1*0202 with DQA1*0505-
DQB1*0301 in heterozygosis). The second group included 
those individuals carrying the DQA1*0501-DQB1*0201 
haplotype along with any other haplotype. The third group 
included those individuals with other common genotypes not 
associated with CD. Of the total number of children, 28.6% 
were in the first group with the highest probability (24-28% 
of developing CD (the high risk group), 33.3% were in the 
second group with a probability of 7-8% of developing CD 
(the intermediate risk group), and 38.1% were in the third 
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group with less than 1% probability of developing CD (the 
low risk group). These probabilities are theoretical and have 
been estimated on basis of the genotype of each newborn, 
without considering the genotype of the affected relative. 
Microbial colonization process in breast-fed children during 
the first 4 months of life
The dynamics of the microbial colonization process from 
7 days till 4 months of life was determined (Table 3). In 
general, most of the analysed bacterial group proportions 
tended to increase with age. Bacteroides-Prevotella 
proportions significantly increase from 7 days to 1 month of 
age (P=0.017), and sulphate-reducing bacteria proportions 
increased from 7 days to 4 months (P=0.009) and from 1 
to 4 months (P=0.021). Staphylococcus proportions also 
increased from 1 to 4 months of age (P=0.086). Statistically 
significant correlations were also found between age and 
bacterial counts for sulphate-reducing bacteria (R=0.356, 
P=0.005) and Gram-negative bacteria (R=0.258, P=0.046). 
 All microbiological data were also analysed as a 
function of the genetic risk to develop CD (Figure 1). Total 
bacterial proportions were significantly higher in the high 
and intermediate genetic risk group than in the low genetic 
risk group (P=0.010 and P=0.030, respectively). Total 
Gram-negative bacterial proportions were higher in the high 
genetic risk group than in the intermediate and low genetic 
risk groups, showing significant differences between the 
high and the low genetic risk groups (P=0.009). In addition, 
significantly higher proportions of Bacteroides-Prevotella 
group were found in children of the high genetic risk group in 
comparison with those of the intermediate and low genetic 
risk groups (P=0.015 and P=0.042, respectively). Similar 
trends were found for E. coli (P=0.011), Streptococcus-
Lactococcus (P=0.003), E. rectale-C. coccoides (P=0.004), 
sulphate-reducing bacteria (P=0.022), C. lituseburense 
(P=0.002) and C. histolyticum (P=0.020) groups, showing 
proportions significantly higher in the high than in the low 
genetic risk group. Significant correlations were also found 
between the genetic risk group of the infants and specific 
bacterial group proportions by applying Spearman correlation 
coefficient (Figure 1). Higher proportions of total Gram-
negative bacteria (R=-0.364, P=0.004), E. coli (R=-0.352, 
P=0.007), Bacteroides-Prevotella (R=-0.265, P=0.046), 
Staphylococcus (R=-0.294, P=0.022), Streptococcus-
Lactococcus (R=-0.386, P=0.002), sulphate-reducing 
bacteria (R=-0.311, P=0.016), E. rectale-C. coccoides 
(R=-0.379, P=0.003), C. histolyticum (R=-0.317, P=0.014) 
and C. lituseburense (R=-0.358, P=0.005) groups were 
correlated with increased genetic risk (Figure 1). 
 When considering the effect of the diseased relatives 
of the children under study, higher proportions of E. coli and 
C. lituseburense groups were observed when the affected 
relative was either the mother or the father than when the 
affected relative was one siblings (P=0.033 and P=0.016, 
respectively). Differences were also observed in bacterial 
proportions between those children, who have one of the 
parents plus one sibling with CD, and those who only have 
one relative (the mother or the father) with CD. In particular, 
E. coli (P=0.042), E. rectale-C. coccoides (P=0.019), 
C. lituseburense (P=0.028), Lactobacillus (P=0.040), 
Streptococcus-Lactococcus (P=0.040), Gram-positive 
bacteria (P=0.019) and total bacteria (P=0.028) were higher 
when the affected relatives were one of the parents together 
with a sibling. Statistically significant correlations were found 
between the CD relative being the mother and increased 
proportions of E. coli (R=0.275, P=0.048), E. rectale-C. 
coccoides (R=0.304, P=0.025), C. lituseburense (R=0.315, 
P=0.019), Lactobacillus, Streptococcus-Lactococcus 
(R=0.272, P=0.047) and Gram positive bacteria (R=0.323, 
P=0.016). 
 When data were adjusted by age, total bacteria 
(P=0.016), Streptococcus-Lactococcus (P=0.010), E. 
rectale-C. coccoides (P=0.093), C. lituseburense (P=0.015), 
C. histolyticum (P=0.015) and Bacteroides-Prevotella 
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Table 3. Microbial colonization process in children at family risk of CD development during the first 4 months of life 
 
7 days  
(n=20) 
1 month  
(n=20) 
4 months  
(n=20) 
Mann –Whitney U-test  
P value Bacterial group 
Group-specific bacteria/EUB(%)  (IQR) 7 d-1 month 7d-4 months 1m-4 months 
Lactobacillus group  2.09 (0.80-2.97) 1.77 (1.20-5.34) 2.81 (1.51-8.21) 0.513 0.095 0.231 
Bifidobacterium  9.20 (6.22-12.20) 10.57 (6.20-25.00) 12.21 (4.17-15.43) 0.234 0.301 0.589 
Streptococcus-Lactococcus 2.85 (1.64-6.01) 2.91 (1.54-7.15) 3.07 (2.02-5.04) 0.925 0.841 0.758 
Staphylococcus 1.99 (1.16-6.57) 2.47 (1.24-7.00) 4.71 (2.83-7.60) 0.678 0.086 0.086 
E. rectale-C. coccoides 1.95 (1.30-4.68) 2.30 (1.20-5.38) 2.22 (1.20-6.63) 0.911 0.813 0.989 
E. coli  2.37 (1.36-4.63) 2.25 (1.43-3.49) 3.13 (1.42-5.72) 0.707 0.515 0.380 
Bacteroides-Prevotella  2.58 (1.36-5.33) 6.15 (3.45-8.58) 4.61 (2.32-8.81)  0.017* 0.125 0.407 
C. histolyticum 2.85 (1.44-6.15) 2.47 (1.47-5.43) 2.76 (1.80-5.36) 0.925 0.718 0.620 
C. lituseburense 2.14 (1.05-5.18) 1.97 (1.34-4.98) 1.62 (1.13-4.76) 0.529 0.947 0.512 
Sulphate-reducing bacteria  1.12 (0.76-3.99) 1.47 (1.06-2.93) 3.62 (1.38-10.11) 0.461 0.009* 0.021* 
‡Sum Gram positive  24.72 (18.54-48.17) 37.57 (17.83-62.65) 32.22 (20.82-66.51) 0.547 0.327 0.718 
‡Sum Gram negative  9.04 (5.16-13.46) 11.37 (7.06-17.92) 12.37 (7.33-32.38) 0.114 0.081 0.417 
‡Sum Total  38.12 (24.24-55.96) 51.27 (22.64-75.63) 42.10 (28.77-53.90) 0.383 0.377 0.874 
 
 ‡Total bacteria, Gram-negative bacteria and Gram-positive bacteria were calculated by adding the relative proportions of the corresponding 
groups related to total bacteria (%specific group/EUB), excluding overlapping probes.   
**Significant differences (P<0.050) between mean values of different group proportions by using the Wilcoxon W-test  
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Figure 1. De Palma et al. 
 
Figure 1. Composition of the faecal microbiota of a cohort of children at family risk of CD development as a function of their HLA-
DQ genotype, considering all data points. Median values of specific-group probe labelled bacteria in relation to total EUB-probe 
labelled bacteria (% Group-specific/EUB) and interquartile ranges (IQR). Correlations between bacterial group proportions and 
the genetic risk (High risk, 24-280% probability; Intermediate risk, 7-8% probability; and low risk <1% probability of developing 
CD) were established by the Spearman’s test and significant differences were defined at P < 0.10 or 0.05. 
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(P=0.100) group proportions were higher in the high genetic 
risk group than in the low genetic risk group at 4 months 
of age. Similar correlations were found between higher 
proportions of these bacterial groups and increased genetic 
risk of CD development (Figure 2). At 7 days and 1 month 
of age similar trends were found but statistical significance 
was not always reached probably due to the limited number 
of studied cases. Interactions between age, genetic risk and 
bacterial proportions were not significant.
Discussion
This is the first follow-up study of the intestinal colonization 
process of the microbiota in children at family risk of 
developing CD. A cohort of first-degree relatives of 
CD patients was analyzed for their HLA class II DQA1 
and DQB1 genotype. These two loci are transmitted in 
haplotypes and encode the alpha and beta-chain that forms 
the DQ heterodimer, a cell surface receptor of antigen 
presenting cells involved in gliadin peptide presentation in 
CD patients. In this study, three groups of different genetic 
risk were defined to establish a possible relationship 
between the HLA-DQ genotype and the gut microbial 
colonization process. This classification was based on the 
recent stratification of CD risk into five classes according to 
the HLA-DQ genotype in European population, which was 
comparable to the Spanish one (Margaritte-Jeannin et al., 
2004 and Bourgey et al., 2007, Capilla et al., 2007, Donat 
et al., 2009). In this work, we have considered the need to 
change the initial five group classification into three main 
groups given our moderate sample size and the absence of 
patient’s genotype. On the other hand, the DQ8 haplotype 
(DQA1*0301-DQB1*0302) was not considered as a coeliac 
risk haplotype by itself in Spanish population, as occurs in 
other European countries. DQ8 haplotype is considered 
as a risk haplotype only in the case that it is transmitted 
in heterozygosis together with the DQA1*0501-DQB1*0201 
or DQA1*0201-DQB1*0202 haplotypes as well as in 
homozygosis with itself, so newborns carrying this genotype 
are included in the second risk group. 
 Overall, the dynamics of the colonization process of the 
whole cohort of children showed similar patterns as those 
reported in previous studies for general population (Fanaro 
et al., 2003; Adlerberth et al., 2007; 2006). In this study, most 
bacterial populations tended to increase with age, particularly 
the strict anaerobic groups Bacteroides-Prevotella and 
sulphate-reducing bacteria and the facultative group 
Staphylococcus. In previous reports, Bacteroides counts 
also increased as the colonization process progressed, 
while levels of facultative anaerobes dropped within the 
first week of life (Fanaro et al., 2003). Nevertheless, in 
this study Staphylococcus levels significantly increased 
in the studied period as reported in other recent cohort 
studies on European and Swedish infants (Adlerberth et al., 
2007; 2006). Human milk that is considered a continuous 
source of commensal bacteria to the infant gut, including 
Staphylococcus species, could partly explain the abundance 
and origin of this bacterial group in the faeces of the studied 
babies under breast-feeding practices (Delgado et al., 
2008). Bifidobacterium genus dominated the microbiota 
of the studied population over the entire period, which is 
characteristic of breast-fed babies, but its proportions did 
not increase with age in agreement with previous studies 
after 3 months of life (Fanaro et al., 2003).
 The study of the effects of the HLA genotype on the 
colonization process revealed an association between 
higher proportions of Bacteroides-Prevotella group and the 
high genetic risk group, compared with the intermediate and 
low genetic risk groups. Total Gram-negative bacteria and E. 
coli, Streptococcus-Lactococcus, E. rectale-C. coccoides, 
C. lituseburense and C. histolyticum group proportions 
followed a similar trend when comparing the high versus 
the low genetic risk groups. In addition, higher levels of all 
these bacterial groups correlated with higher genetic risk. An 
increased number of affected coeliac relatives as well as the 
mother being the affected relative seemed to be associated 
with higher proportions of bacterial groups (E. coli, E. 
rectale-C. coccoides, C. lituseburense and Streptococcus-
Lactococcus) related to increased CD risk in children. These 
results suggest that the features of the affected relative’s 
microbiota could partially be transferred to the newborns 
with higher probability in both cases. Similar associations 
between increased Streptococcus-Lactococcus, E. rectale- 
C. coccoides, C. lituseburense, C. histolyticum and 
Bacteroides-Prevotella proportions and increased genetic 
risk of CD development were detected at 4 months. These 
preliminary results suggest that HLA class II molecules of 
the MHC could be a genetic host factor modulating the gut 
microbial colonization process and thereby disease risk. 
In murine models, it has been suggested that the MHC is 
one of the genetic factors exerting a pronounced influence 
on composition of the faecal microbiota using diverse 
mouse strains congenic for MHC (Toivanen et al., 2001). 
In human subjects, the only evidence of the influence of 
the genetic background in the structure of the intestinal 
microbiota is based on comparisons between twins and 
non-genetic related individuals, showing that subjects with 
a common genetic background had the highest similarities 
in their gut microbiota (Stewart et al., 2005; Palmer et al., 
2007; Dicksved et al., 2008). MHC genes are responsible 
for encoding cell-surface antigen-presenting proteins that 
have a vital role in the immunological dialogue that occurs 
between T cells and other cells involved in autoimmune 
disorders. Many autoimmune conditions have close 
genetic linkages to particular human HLA class II genes, 
such as CD, type-1 diabetes and rheumatoid arthritis. CD 
and rheumatoid arthritis have also been associated with 
imbalances in the intestinal microbiota particularly in newly 
diagnosed patients (Nadal et al., 2007; Vaahtovuo et al., 
2008; Thompson-Chagoyán et al., 2007; Wen et al., 2008). 
MHC genes together with non-MHC autosomal genes 
have also been associated with susceptibility to infectious 
agents such as Helicobacter felis, Listeria monocytogenes 
and Salmonella enterica serovar Typhimurium (Plant and 
Glynn, 1976; Gervais et al, 1984; Mohammadi et al., 1996). 
In particular, HLA-DQ genes have been shown to influence 
the host response against Helicobacter pylori and the HLA-
DQB1 genotype, which is also associated with CD and 
type-1 diabetes, was related to development of atrophic 
gastritis in H. pylori-infected patients (Sakai et al., 1999). In 
addition, higher incidence of infections, which can promote a 
Th1 protective immune response, has also been associated 
with increased risk of developing CD in early life (Ivarsson 
et al., 2003, Sanz et al., 2008). 
 Although the knowledge of the mechanisms by 
which MHC and particularly HLA-DQ molecules could 
influence the gut microbiota composition will require 
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Figure 2. Composition of the faecal microbiota of a cohort of children at family risk of CD development as a function of their 
HLA-DQ genotype at 4 months of age. Median values of specific-group probe labelled bacteria in relation to total EUB-probe 
labelled bacteria (% Group-specific/EUB) and interquartile ranges (IQR). Correlations between bacterial group proportions and 
the genetic risk (High risk, 24-28% probability; Intermediate risk, 7-8% probability; and low risk <1% probability of developing 
CD) were established by the Spearman’s test and significant differences were defined at P < 0.10 or 0.05. 
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further investigations, these molecules could be involved in 
immune activation leading to tolerance or elimination of the 
microbe. Intestinal dendritic cells act as sentinels, sampling 
the mucosal surface for dietary or microbial antigens, 
thereby activating antigen presentation and specific T-cell 
responses that could favour tolerance to specific bacterial 
groups or facilitate their immune elimination modifying their 
relative proportions (Winkler et al., 2007). 
 Given that the major source of microbial stimuli in 
infancy is the gut microbiota, its distinctive characteristics 
in each infant may differently influence host physiology and 
immune responses, leading to either tolerance or a biased 
Th1 or Th2 cytokine response and thereby to disease 
(Hessle et al., 2000; Kalliomaki et al., 2001a; Adlerberth et 
al., 2007). The development of atopy has been shown to be 
preceded by deviations in gut microbiota, characterized by 
lower prevalence of Gram-positive anaerobes and a higher 
ratio of clostridia to bifidobacteria at neonatal age (Penders 
et al., 2007; Kalliomaki et al., 2001a). In addition, studies 
in 1-year-old healthy Swedish and Estonian children, which 
represent two population groups with high and low incidence 
of CD and allergy, respectively, also showed increased 
levels of Clostridium in Swedish group (Sepp et al., 1997). 
In addition, Bacteroides and Clostridium were those groups 
present in many Swedish infants, while not in Estonian 
infants (Sepp et al., 1997). 
 In summary, the obtained results suggest a relationship 
between the HLA-DQ genes and the colonization process 
of the gut microbiota at early life, which could play a role 
in the risk to develop CD. Further work is in progress to 
confirm these preliminary observations that could lead to 
a significant change in the way autoimmune disorders and 
their therapies are investigated.
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